After Hours Gainer
INVA Innoviva12.020.000.0%
After Hours:13.30+1.28 (+10.7%)
Sulbactam-Durlobactam Unanimously Recommended for Approval by FDA Advisory Committee
Business WireMon, 17-Apr 4:31 PM
After Hours Gainer
INVA Innoviva12.020.000.0%
After Hours:13.23+1.21 (+10.1%)
Sulbactam-Durlobactam Unanimously Recommended for Approval by FDA Advisory Committee
Business WireMon, 17-Apr 4:31 PM
INVA Innoviva17.05-0.16 (-0.9%)